Binimetinib

Generic name: Binimetinib
Brand names: Mektovi
Dosage form: oral tablet (15 mg)
Drug class: Multikinase inhibitors

Usage of Binimetinib

Binimetinib is used in combination with another medicine called encorafenib (Braftovi) to treat melanoma (skin cancer) in people who have a "BRAF" gene mutation. These medicines are for use in treating melanoma that cannot be treated with surgery or has spread to other parts of the body.

Binimetinib may also be used for purposes not listed in this medication guide.

Binimetinib side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Some side effects are more likely to occur if you take binimetinib and encorafenib together. Call your doctor at once if you have:

cough, shortness of breath;

unexplained muscle pain, tenderness, or weakness;

eye pain or swelling, vision changes, seeing halos around lights, seeing color "dots" in your vision;

severe skin rash, skin pain or swelling, redness and peeling skin on your hands or feet;

liver problems--nausea, vomiting, loss of appetite, dark urine, jaundice (yellowing of the skin or eyes);

signs of bleeding--weakness, dizziness, headache, bloody or tarry stools, coughing up blood or vomit that looks like coffee grounds;

signs of a blood clot--chest pain, sudden cough or trouble breathing, pain or swelling in an arm or leg, pale skin, cold feeling in an arm or leg; or

signs of a heart problem--shortness of breath (even with mild exertion), pounding heartbeats, swelling in your feet or ankles.

Common side effects of binimetinib may include:

nausea, vomiting, stomach pain;

diarrhea; or

feeling tired.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Binimetinib

You should not use binimetinib if you are allergic to it.

Tell your doctor if you have ever had:

heart disease, high blood pressure;

lung disease;

a muscle disorder;

liver or kidney disease;

eye problems (especially a problem with your retina); or

bleeding problems, or a blood clot.

Do not use binimetinib if you are pregnant. It could harm the unborn baby or cause birth defects. Use effective birth control to prevent pregnancy while you are using binimetinib and for at least 30 days after your last dose.

Tell your doctor if you think you may be pregnant. You may need to have a negative pregnancy test before starting this treatment.

You should not breastfeed while using this medicine, and for at least 3 days after your last dose.

Relate drugs

How to use Binimetinib

Usual Adult Dose for Melanoma -- Metastatic:

45 mg orally every 12 hours in combination with encorafenib until disease progression or unacceptable toxicityComments:-Refer to the encorafenib prescribing information for encorafenib dosing information.-This drug may be taken with or without food.-Do not take a missed dose within 6 hours of the next dose.-Do not take an additional dose if vomiting occurs after administration but continue with the next scheduled dose.Use: In combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test

Warnings

Binimetinib can cause birth defects. Do not use if you are pregnant. Avoid getting pregnant while using binimetinib and for at least 30 days after your last dose.

What other drugs will affect Binimetinib

Other drugs may affect binimetinib, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Popular FAQ

Mektovi is used in combination with another medicine called encorafenib (Braftovi) to treat advanced forms of melanoma (skin cancer) and non-small cell lung cancer with certain BRAF gene mutations. Continue reading

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.